Would you recommend allogeneic stem cell transplantation for consolidation in a patient with follicular lymphoma who relapsed within 13 months of initial chemo-immunotherapy?  

Are there still scenarios where you would employ transplant for r/r FL following chemo-immunotherapy?

• Yes, in fit patients with refractoriness to initial therapy (progression <12 mos)
• Yes, in fit patients with overall early relapse (progression <24 mos)
• Yes, in early relapse (progression <24 mos) and logistical delay in other cellular therapy (CAR-T or Bispecifics)
• No, mainly using CAR-T ahead or in place of transplant
• No, mainly using bispecific antibodies ahead or in place of transplant
• Other